06 - 07 September 2021 | London, UK
+ Digital Day: 08 September 2021 | Online

David Cole

Collaboration and Discovery Research Lead
Immunocore
David Cole
Dr David Cole currently leads Collaboration Research at Immunocore, a privately funded biotech just outside of Oxford that is developing novel bispecific T cell engagers using engineered T cell receptor technology. Before moving to Immunocore in 2017, David spent a number of years in academia, completing his PhD at Oxford University in 2007, before setting up his own laboratory at Cardiff University in 2009. During his academic career, David used a variety of molecular approaches (X-ray crystallography, biophysics, protein engineering) to better understand the nature of T cell antigen recognition, which is governed by the interaction between the T cell receptor and peptide-human leukocyte antigen. In his current role at Immunocore, he is now applying this fundamental understanding of T cell receptors to help develop novel drugs to treat cancer.

Sessions

No data was found

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.